Entrada Therapeutics reported total assets of $298.88M and total liabilities of $65.47M for the quarter ended Jun 2026, down 33.4% year over year. This balance sheet covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 1.05M | 1.42M | ||||||||||||||||||||||
| Assets | ||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 122.20M | 291.06M | 84.64M | 90.87M | 53.31M | 45.16M | 227.65M | 79.74M | 51.88M | 67.60M | 68.44M | 185.25M | 78.05M | 101.21M | 67.84M | 72.48M | 93.29M | 90.39M | 76.44M | 99.28M | ||||
| Receivables - NetNet Receivables | 6.30M | 3.74M | 5.03M | 5.88M | 77.51M | 7.67M | 2.60M | 3.68M | 2.04M | 1.18M | 1.20M | 1.18M | 0.79M | 0.82M | ||||||||||
| Receivables | 6.30M | 3.74M | 5.03M | 5.88M | 77.51M | 7.67M | 2.60M | 3.68M | 2.04M | 1.18M | 1.20M | 1.18M | 0.79M | 0.82M | ||||||||||
| Prepaid Assets | 1.35M | 7.64M | 8.81M | 9.65M | 19.16M | 21.16M | 16.21M | 9.66M | 24.44M | 11.92M | 9.24M | 12.12M | 13.39M | 16.36M | 18.63M | 13.95M | 10.22M | 8.72M | 11.23M | 8.88M | ||||
| Current Assets | 123.53M | 298.70M | 272.71M | 253.90M | 234.73M | 209.88M | 434.13M | 390.19M | 383.04M | 369.77M | 414.17M | 489.54M | 465.33M | 440.04M | 403.19M | 369.15M | 338.26M | 306.25M | 266.87M | 232.70M | ||||
| Non-Current Assets | ||||||||||||||||||||||||
| Property, Plant & Equipment (Net) | 5.90M | 6.26M | 7.20M | 7.79M | 7.44M | 7.68M | 9.39M | 11.02M | 11.04M | 11.19M | 11.00M | 11.34M | 10.79M | 10.93M | 10.67M | 9.81M | 8.41M | 7.31M | 6.51M | 5.72M | ||||
| Other Non-Current Assets | 2.97M | 0.87M | 3.95M | 3.95M | 3.95M | 5.21M | 13.84M | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | 3.95M | 4.00M | 3.95M | 3.95M | 3.95M | 3.29M | 3.29M | 3.29M | ||||
| Non-Current Assets | 8.87M | 7.13M | 43.99M | 42.01M | 39.73M | 42.18M | 41.43M | 103.79M | 101.99M | 99.42M | 96.67M | 92.43M | 89.25M | 86.28M | 83.29M | 79.64M | 74.64M | 71.13M | 68.65M | 66.17M | ||||
| Assets | 132.40M | 305.83M | 316.70M | 295.92M | 274.46M | 252.06M | 475.57M | 493.98M | 485.03M | 469.19M | 510.84M | 581.96M | 554.59M | 526.32M | 486.48M | 448.78M | 412.90M | 377.38M | 335.52M | 298.88M | ||||
| Liabilities | ||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||
| Accounts Payables | 2.28M | 0.71M | 2.93M | 4.62M | 1.34M | 5.99M | 6.47M | 2.42M | 0.75M | 3.28M | 2.53M | 1.64M | 1.29M | 4.26M | 2.19M | 1.86M | 3.17M | 2.29M | 2.93M | 3.75M | ||||
| Payables | 2.28M | 0.71M | 2.93M | 4.62M | 1.34M | 5.99M | 6.47M | 2.42M | 0.75M | 3.28M | 2.53M | 1.64M | 1.29M | 4.26M | 2.19M | 1.86M | 3.17M | 2.29M | 2.93M | 3.75M | ||||
| Accumulated Expenses | 4.88M | 6.01M | 4.52M | 5.34M | 11.95M | 7.58M | 11.68M | 7.11M | 9.60M | 11.32M | 8.79M | 11.00M | 13.40M | 13.34M | 7.58M | 11.79M | 15.53M | 17.68M | 11.73M | 13.00M | ||||
| Other Accumulated Expenses | 0.33M | 0.48M | ||||||||||||||||||||||
| Current Leases | 7.97M | 8.11M | 8.26M | 8.41M | 7.10M | 7.41M | 6.64M | 7.91M | 8.30M | 8.57M | 7.74M | 7.56M | 6.51M | 5.46M | 4.35M | 4.14M | 4.28M | 4.45M | ||||||
| Current Taxes | 7.36M | 4.02M | 5.86M | 4.11M | 2.25M | 0.67M | 0.80M | 0.62M | ||||||||||||||||
| Current Deferred Revenue | 122.34M | 101.64M | 148.44M | 132.26M | 148.46M | 60.50M | 45.92M | 13.65M | 1.35M | 0.69M | 0.35M | 0.34M | 0.25M | 0.17M | ||||||||||
| Total Current Liabilities | 7.16M | 6.72M | 15.43M | 18.08M | 21.55M | 21.97M | 147.59M | 125.94M | 165.43M | 158.80M | 173.94M | 85.81M | 70.60M | 39.48M | 18.43M | 19.80M | 24.02M | 24.45M | 19.20M | 21.37M | ||||
| Non-Current Liabilities | ||||||||||||||||||||||||
| Non-Current Deffered Revenue | 0.34M | 0.40M | ||||||||||||||||||||||
| Preferred Stock Liabilities | 197.49M | |||||||||||||||||||||||
| Operating Leases | 31.86M | 29.91M | 27.95M | 17.53M | 16.23M | 73.03M | 69.07M | 60.32M | 58.13M | 55.88M | 53.58M | 51.65M | 50.49M | 49.28M | 48.05M | 46.79M | 45.47M | 44.09M | ||||||
| Total Liabilities | 7.50M | 7.12M | 39.31M | 39.88M | 41.24M | 39.50M | 245.96M | 287.07M | 238.37M | 226.83M | 241.48M | 152.04M | 132.14M | 97.64M | 69.22M | 69.28M | 72.18M | 71.25M | 64.66M | 65.47M | ||||
| Shareholder's Equity | ||||||||||||||||||||||||
| Common Equity | -72.59M | 298.72M | 277.39M | 256.04M | 233.22M | 212.55M | 229.61M | 206.91M | 246.66M | 242.36M | 269.37M | 429.93M | 422.45M | 428.68M | 417.26M | 379.50M | 340.72M | 306.13M | 270.85M | 233.41M | ||||
| Liabilities and Shareholders Equity | 132.40M | 305.83M | 316.70M | 295.92M | 274.46M | 252.06M | 475.57M | 493.98M | 485.03M | 469.19M | 510.84M | 581.96M | 554.59M | 526.32M | 486.48M | 448.78M | 412.90M | 377.38M | 335.52M | 298.88M | ||||
| Retained Earnings | -75.22M | 392.38M | 394.26M | 396.82M | 399.62M | 402.89M | 425.21M | 428.80M | 432.58M | 437.13M | 441.08M | 546.69M | 551.95M | 558.06M | 563.51M | 568.90M | 574.02M | 578.57M | 583.41M | 588.91M | ||||
| Treasury Shares | 138.82M |